| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.022 | 0.6 |